Global Amyotrophic Lateral Sclerosis Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.
The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.
According to our (Global Info Research) latest study, the global Amyotrophic Lateral Sclerosis Treatment market size was valued at USD 308.7 million in 2022 and is forecast to a readjusted size of USD 385.8 million by 2029 with a CAGR of 3.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
GlobalAmyotrophic Lateral Sclerosis (ALS) Treatment key players include Mitsubishi Tanabe Pharma, Sanofi, etc. Global top two manufacturers hold a share over 80%.
North America is the largest market, with a share about 60%, followed by Japan, and Europe, both have a share over 20 percent.
In terms of product, Edaravone (Radicava) is the largest segment, with a share over 75%. And in terms of application, the largest application is Hospital, followed by Drugs Store, etc.
This report is a detailed and comprehensive analysis for global Amyotrophic Lateral Sclerosis Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Amyotrophic Lateral Sclerosis Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Amyotrophic Lateral Sclerosis Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Amyotrophic Lateral Sclerosis Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Amyotrophic Lateral Sclerosis Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Amyotrophic Lateral Sclerosis Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Amyotrophic Lateral Sclerosis Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Roche, Biogen, Mitsubishi Tanabe Pharma and GNT Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Amyotrophic Lateral Sclerosis Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Amyotrophic Lateral Sclerosis Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Amyotrophic Lateral Sclerosis Treatment, with revenue, gross margin and global market share of Amyotrophic Lateral Sclerosis Treatment from 2018 to 2023.
Chapter 3, the Amyotrophic Lateral Sclerosis Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Amyotrophic Lateral Sclerosis Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Amyotrophic Lateral Sclerosis Treatment.
Chapter 13, to describe Amyotrophic Lateral Sclerosis Treatment research findings and conclusion.
The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person's parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person's signs and symptoms, with testing done to rule out other potential causes.
According to our (Global Info Research) latest study, the global Amyotrophic Lateral Sclerosis Treatment market size was valued at USD 308.7 million in 2022 and is forecast to a readjusted size of USD 385.8 million by 2029 with a CAGR of 3.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
GlobalAmyotrophic Lateral Sclerosis (ALS) Treatment key players include Mitsubishi Tanabe Pharma, Sanofi, etc. Global top two manufacturers hold a share over 80%.
North America is the largest market, with a share about 60%, followed by Japan, and Europe, both have a share over 20 percent.
In terms of product, Edaravone (Radicava) is the largest segment, with a share over 75%. And in terms of application, the largest application is Hospital, followed by Drugs Store, etc.
This report is a detailed and comprehensive analysis for global Amyotrophic Lateral Sclerosis Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Amyotrophic Lateral Sclerosis Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global Amyotrophic Lateral Sclerosis Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Amyotrophic Lateral Sclerosis Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Amyotrophic Lateral Sclerosis Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Amyotrophic Lateral Sclerosis Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Amyotrophic Lateral Sclerosis Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Roche, Biogen, Mitsubishi Tanabe Pharma and GNT Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Amyotrophic Lateral Sclerosis Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Medication
- Physical Therapy
- Speech Therapy
- Others
- Hospitals
- Specialty Centers
- Research Centers
- Others
- Sanofi
- Roche
- Biogen
- Mitsubishi Tanabe Pharma
- GNT Pharma
- Synthetic Biologics
- Amkor Pharma
- ViroMed
- Brainstorm Therapeutics
- Bausch Health
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Amyotrophic Lateral Sclerosis Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Amyotrophic Lateral Sclerosis Treatment, with revenue, gross margin and global market share of Amyotrophic Lateral Sclerosis Treatment from 2018 to 2023.
Chapter 3, the Amyotrophic Lateral Sclerosis Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Amyotrophic Lateral Sclerosis Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Amyotrophic Lateral Sclerosis Treatment.
Chapter 13, to describe Amyotrophic Lateral Sclerosis Treatment research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Amyotrophic Lateral Sclerosis Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Amyotrophic Lateral Sclerosis Treatment by Type
1.3.1 Overview: Global Amyotrophic Lateral Sclerosis Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Type in 2022
1.3.3 Medication
1.3.4 Physical Therapy
1.3.5 Speech Therapy
1.3.6 Others
1.4 Global Amyotrophic Lateral Sclerosis Treatment Market by Application
1.4.1 Overview: Global Amyotrophic Lateral Sclerosis Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Specialty Centers
1.4.4 Research Centers
1.4.5 Others
1.5 Global Amyotrophic Lateral Sclerosis Treatment Market Size & Forecast
1.6 Global Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast by Region
1.6.1 Global Amyotrophic Lateral Sclerosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Amyotrophic Lateral Sclerosis Treatment Market Size by Region, (2018-2029)
1.6.3 North America Amyotrophic Lateral Sclerosis Treatment Market Size and Prospect (2018-2029)
1.6.4 Europe Amyotrophic Lateral Sclerosis Treatment Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size and Prospect (2018-2029)
1.6.6 South America Amyotrophic Lateral Sclerosis Treatment Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.1.4 Sanofi Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.2.4 Roche Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Roche Recent Developments and Future Plans
2.3 Biogen
2.3.1 Biogen Details
2.3.2 Biogen Major Business
2.3.3 Biogen Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.3.4 Biogen Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Biogen Recent Developments and Future Plans
2.4 Mitsubishi Tanabe Pharma
2.4.1 Mitsubishi Tanabe Pharma Details
2.4.2 Mitsubishi Tanabe Pharma Major Business
2.4.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.4.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mitsubishi Tanabe Pharma Recent Developments and Future Plans
2.5 GNT Pharma
2.5.1 GNT Pharma Details
2.5.2 GNT Pharma Major Business
2.5.3 GNT Pharma Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.5.4 GNT Pharma Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GNT Pharma Recent Developments and Future Plans
2.6 Synthetic Biologics
2.6.1 Synthetic Biologics Details
2.6.2 Synthetic Biologics Major Business
2.6.3 Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.6.4 Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Synthetic Biologics Recent Developments and Future Plans
2.7 Amkor Pharma
2.7.1 Amkor Pharma Details
2.7.2 Amkor Pharma Major Business
2.7.3 Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.7.4 Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Amkor Pharma Recent Developments and Future Plans
2.8 ViroMed
2.8.1 ViroMed Details
2.8.2 ViroMed Major Business
2.8.3 ViroMed Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.8.4 ViroMed Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 ViroMed Recent Developments and Future Plans
2.9 Brainstorm Therapeutics
2.9.1 Brainstorm Therapeutics Details
2.9.2 Brainstorm Therapeutics Major Business
2.9.3 Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.9.4 Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Brainstorm Therapeutics Recent Developments and Future Plans
2.10 Bausch Health
2.10.1 Bausch Health Details
2.10.2 Bausch Health Major Business
2.10.3 Bausch Health Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.10.4 Bausch Health Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bausch Health Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Amyotrophic Lateral Sclerosis Treatment Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Amyotrophic Lateral Sclerosis Treatment by Company Revenue
3.2.2 Top 3 Amyotrophic Lateral Sclerosis Treatment Players Market Share in 2022
3.2.3 Top 6 Amyotrophic Lateral Sclerosis Treatment Players Market Share in 2022
3.3 Amyotrophic Lateral Sclerosis Treatment Market: Overall Company Footprint Analysis
3.3.1 Amyotrophic Lateral Sclerosis Treatment Market: Region Footprint
3.3.2 Amyotrophic Lateral Sclerosis Treatment Market: Company Product Type Footprint
3.3.3 Amyotrophic Lateral Sclerosis Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Amyotrophic Lateral Sclerosis Treatment Consumption Value and Market Share by Type (2018-2023)
4.2 Global Amyotrophic Lateral Sclerosis Treatment Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Application (2018-2023)
5.2 Global Amyotrophic Lateral Sclerosis Treatment Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2029)
6.2 North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2029)
6.3 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Country
6.3.1 North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2029)
6.3.2 United States Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
6.3.3 Canada Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
6.3.4 Mexico Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2029)
7.2 Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2029)
7.3 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Country
7.3.1 Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2029)
7.3.2 Germany Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
7.3.3 France Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
7.3.5 Russia Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
7.3.6 Italy Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Region
8.3.1 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Region (2018-2029)
8.3.2 China Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
8.3.3 Japan Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
8.3.4 South Korea Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
8.3.5 India Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
8.3.7 Australia Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2029)
9.2 South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2029)
9.3 South America Amyotrophic Lateral Sclerosis Treatment Market Size by Country
9.3.1 South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2029)
9.3.2 Brazil Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
9.3.3 Argentina Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Country
10.3.1 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2029)
10.3.2 Turkey Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
10.3.4 UAE Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Amyotrophic Lateral Sclerosis Treatment Market Drivers
11.2 Amyotrophic Lateral Sclerosis Treatment Market Restraints
11.3 Amyotrophic Lateral Sclerosis Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Amyotrophic Lateral Sclerosis Treatment Industry Chain
12.2 Amyotrophic Lateral Sclerosis Treatment Upstream Analysis
12.3 Amyotrophic Lateral Sclerosis Treatment Midstream Analysis
12.4 Amyotrophic Lateral Sclerosis Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Amyotrophic Lateral Sclerosis Treatment
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Amyotrophic Lateral Sclerosis Treatment by Type
1.3.1 Overview: Global Amyotrophic Lateral Sclerosis Treatment Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Type in 2022
1.3.3 Medication
1.3.4 Physical Therapy
1.3.5 Speech Therapy
1.3.6 Others
1.4 Global Amyotrophic Lateral Sclerosis Treatment Market by Application
1.4.1 Overview: Global Amyotrophic Lateral Sclerosis Treatment Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Specialty Centers
1.4.4 Research Centers
1.4.5 Others
1.5 Global Amyotrophic Lateral Sclerosis Treatment Market Size & Forecast
1.6 Global Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast by Region
1.6.1 Global Amyotrophic Lateral Sclerosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Amyotrophic Lateral Sclerosis Treatment Market Size by Region, (2018-2029)
1.6.3 North America Amyotrophic Lateral Sclerosis Treatment Market Size and Prospect (2018-2029)
1.6.4 Europe Amyotrophic Lateral Sclerosis Treatment Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size and Prospect (2018-2029)
1.6.6 South America Amyotrophic Lateral Sclerosis Treatment Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.1.4 Sanofi Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.2.4 Roche Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Roche Recent Developments and Future Plans
2.3 Biogen
2.3.1 Biogen Details
2.3.2 Biogen Major Business
2.3.3 Biogen Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.3.4 Biogen Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Biogen Recent Developments and Future Plans
2.4 Mitsubishi Tanabe Pharma
2.4.1 Mitsubishi Tanabe Pharma Details
2.4.2 Mitsubishi Tanabe Pharma Major Business
2.4.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.4.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mitsubishi Tanabe Pharma Recent Developments and Future Plans
2.5 GNT Pharma
2.5.1 GNT Pharma Details
2.5.2 GNT Pharma Major Business
2.5.3 GNT Pharma Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.5.4 GNT Pharma Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 GNT Pharma Recent Developments and Future Plans
2.6 Synthetic Biologics
2.6.1 Synthetic Biologics Details
2.6.2 Synthetic Biologics Major Business
2.6.3 Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.6.4 Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Synthetic Biologics Recent Developments and Future Plans
2.7 Amkor Pharma
2.7.1 Amkor Pharma Details
2.7.2 Amkor Pharma Major Business
2.7.3 Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.7.4 Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Amkor Pharma Recent Developments and Future Plans
2.8 ViroMed
2.8.1 ViroMed Details
2.8.2 ViroMed Major Business
2.8.3 ViroMed Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.8.4 ViroMed Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 ViroMed Recent Developments and Future Plans
2.9 Brainstorm Therapeutics
2.9.1 Brainstorm Therapeutics Details
2.9.2 Brainstorm Therapeutics Major Business
2.9.3 Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.9.4 Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Brainstorm Therapeutics Recent Developments and Future Plans
2.10 Bausch Health
2.10.1 Bausch Health Details
2.10.2 Bausch Health Major Business
2.10.3 Bausch Health Amyotrophic Lateral Sclerosis Treatment Product and Solutions
2.10.4 Bausch Health Amyotrophic Lateral Sclerosis Treatment Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Bausch Health Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Amyotrophic Lateral Sclerosis Treatment Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Amyotrophic Lateral Sclerosis Treatment by Company Revenue
3.2.2 Top 3 Amyotrophic Lateral Sclerosis Treatment Players Market Share in 2022
3.2.3 Top 6 Amyotrophic Lateral Sclerosis Treatment Players Market Share in 2022
3.3 Amyotrophic Lateral Sclerosis Treatment Market: Overall Company Footprint Analysis
3.3.1 Amyotrophic Lateral Sclerosis Treatment Market: Region Footprint
3.3.2 Amyotrophic Lateral Sclerosis Treatment Market: Company Product Type Footprint
3.3.3 Amyotrophic Lateral Sclerosis Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Amyotrophic Lateral Sclerosis Treatment Consumption Value and Market Share by Type (2018-2023)
4.2 Global Amyotrophic Lateral Sclerosis Treatment Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Application (2018-2023)
5.2 Global Amyotrophic Lateral Sclerosis Treatment Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2029)
6.2 North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2029)
6.3 North America Amyotrophic Lateral Sclerosis Treatment Market Size by Country
6.3.1 North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2029)
6.3.2 United States Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
6.3.3 Canada Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
6.3.4 Mexico Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2029)
7.2 Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2029)
7.3 Europe Amyotrophic Lateral Sclerosis Treatment Market Size by Country
7.3.1 Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2029)
7.3.2 Germany Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
7.3.3 France Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
7.3.5 Russia Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
7.3.6 Italy Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market Size by Region
8.3.1 Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Region (2018-2029)
8.3.2 China Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
8.3.3 Japan Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
8.3.4 South Korea Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
8.3.5 India Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
8.3.7 Australia Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2029)
9.2 South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2029)
9.3 South America Amyotrophic Lateral Sclerosis Treatment Market Size by Country
9.3.1 South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2029)
9.3.2 Brazil Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
9.3.3 Argentina Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market Size by Country
10.3.1 Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2029)
10.3.2 Turkey Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
10.3.4 UAE Amyotrophic Lateral Sclerosis Treatment Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Amyotrophic Lateral Sclerosis Treatment Market Drivers
11.2 Amyotrophic Lateral Sclerosis Treatment Market Restraints
11.3 Amyotrophic Lateral Sclerosis Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Amyotrophic Lateral Sclerosis Treatment Industry Chain
12.2 Amyotrophic Lateral Sclerosis Treatment Upstream Analysis
12.3 Amyotrophic Lateral Sclerosis Treatment Midstream Analysis
12.4 Amyotrophic Lateral Sclerosis Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Sanofi Company Information, Head Office, and Major Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 8. Sanofi Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Sanofi Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 13. Roche Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Roche Recent Developments and Future Plans
Table 15. Biogen Company Information, Head Office, and Major Competitors
Table 16. Biogen Major Business
Table 17. Biogen Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 18. Biogen Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Biogen Recent Developments and Future Plans
Table 20. Mitsubishi Tanabe Pharma Company Information, Head Office, and Major Competitors
Table 21. Mitsubishi Tanabe Pharma Major Business
Table 22. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 23. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Mitsubishi Tanabe Pharma Recent Developments and Future Plans
Table 25. GNT Pharma Company Information, Head Office, and Major Competitors
Table 26. GNT Pharma Major Business
Table 27. GNT Pharma Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 28. GNT Pharma Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. GNT Pharma Recent Developments and Future Plans
Table 30. Synthetic Biologics Company Information, Head Office, and Major Competitors
Table 31. Synthetic Biologics Major Business
Table 32. Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 33. Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Synthetic Biologics Recent Developments and Future Plans
Table 35. Amkor Pharma Company Information, Head Office, and Major Competitors
Table 36. Amkor Pharma Major Business
Table 37. Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 38. Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Amkor Pharma Recent Developments and Future Plans
Table 40. ViroMed Company Information, Head Office, and Major Competitors
Table 41. ViroMed Major Business
Table 42. ViroMed Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 43. ViroMed Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. ViroMed Recent Developments and Future Plans
Table 45. Brainstorm Therapeutics Company Information, Head Office, and Major Competitors
Table 46. Brainstorm Therapeutics Major Business
Table 47. Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 48. Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Brainstorm Therapeutics Recent Developments and Future Plans
Table 50. Bausch Health Company Information, Head Office, and Major Competitors
Table 51. Bausch Health Major Business
Table 52. Bausch Health Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 53. Bausch Health Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Bausch Health Recent Developments and Future Plans
Table 55. Global Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million) by Players (2018-2023)
Table 56. Global Amyotrophic Lateral Sclerosis Treatment Revenue Share by Players (2018-2023)
Table 57. Breakdown of Amyotrophic Lateral Sclerosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Amyotrophic Lateral Sclerosis Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Amyotrophic Lateral Sclerosis Treatment Players
Table 60. Amyotrophic Lateral Sclerosis Treatment Market: Company Product Type Footprint
Table 61. Amyotrophic Lateral Sclerosis Treatment Market: Company Product Application Footprint
Table 62. Amyotrophic Lateral Sclerosis Treatment New Market Entrants and Barriers to Market Entry
Table 63. Amyotrophic Lateral Sclerosis Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Share by Type (2018-2023)
Table 66. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Forecast by Type (2024-2029)
Table 67. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2023)
Table 68. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Forecast by Application (2024-2029)
Table 69. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Amyotrophic Lateral Sclerosis Treatment Raw Material
Table 100. Key Suppliers of Amyotrophic Lateral Sclerosis Treatment Raw Materials
Table 1. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Sanofi Company Information, Head Office, and Major Competitors
Table 6. Sanofi Major Business
Table 7. Sanofi Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 8. Sanofi Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Sanofi Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 13. Roche Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Roche Recent Developments and Future Plans
Table 15. Biogen Company Information, Head Office, and Major Competitors
Table 16. Biogen Major Business
Table 17. Biogen Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 18. Biogen Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Biogen Recent Developments and Future Plans
Table 20. Mitsubishi Tanabe Pharma Company Information, Head Office, and Major Competitors
Table 21. Mitsubishi Tanabe Pharma Major Business
Table 22. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 23. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Mitsubishi Tanabe Pharma Recent Developments and Future Plans
Table 25. GNT Pharma Company Information, Head Office, and Major Competitors
Table 26. GNT Pharma Major Business
Table 27. GNT Pharma Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 28. GNT Pharma Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. GNT Pharma Recent Developments and Future Plans
Table 30. Synthetic Biologics Company Information, Head Office, and Major Competitors
Table 31. Synthetic Biologics Major Business
Table 32. Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 33. Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Synthetic Biologics Recent Developments and Future Plans
Table 35. Amkor Pharma Company Information, Head Office, and Major Competitors
Table 36. Amkor Pharma Major Business
Table 37. Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 38. Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Amkor Pharma Recent Developments and Future Plans
Table 40. ViroMed Company Information, Head Office, and Major Competitors
Table 41. ViroMed Major Business
Table 42. ViroMed Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 43. ViroMed Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. ViroMed Recent Developments and Future Plans
Table 45. Brainstorm Therapeutics Company Information, Head Office, and Major Competitors
Table 46. Brainstorm Therapeutics Major Business
Table 47. Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 48. Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Brainstorm Therapeutics Recent Developments and Future Plans
Table 50. Bausch Health Company Information, Head Office, and Major Competitors
Table 51. Bausch Health Major Business
Table 52. Bausch Health Amyotrophic Lateral Sclerosis Treatment Product and Solutions
Table 53. Bausch Health Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Bausch Health Recent Developments and Future Plans
Table 55. Global Amyotrophic Lateral Sclerosis Treatment Revenue (USD Million) by Players (2018-2023)
Table 56. Global Amyotrophic Lateral Sclerosis Treatment Revenue Share by Players (2018-2023)
Table 57. Breakdown of Amyotrophic Lateral Sclerosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Amyotrophic Lateral Sclerosis Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Amyotrophic Lateral Sclerosis Treatment Players
Table 60. Amyotrophic Lateral Sclerosis Treatment Market: Company Product Type Footprint
Table 61. Amyotrophic Lateral Sclerosis Treatment Market: Company Product Application Footprint
Table 62. Amyotrophic Lateral Sclerosis Treatment New Market Entrants and Barriers to Market Entry
Table 63. Amyotrophic Lateral Sclerosis Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Share by Type (2018-2023)
Table 66. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Forecast by Type (2024-2029)
Table 67. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2023)
Table 68. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Forecast by Application (2024-2029)
Table 69. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Amyotrophic Lateral Sclerosis Treatment Raw Material
Table 100. Key Suppliers of Amyotrophic Lateral Sclerosis Treatment Raw Materials
LIST OF FIGURES
Figure 1. Amyotrophic Lateral Sclerosis Treatment Picture
Figure 2. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Type in 2022
Figure 4. Medication
Figure 5. Physical Therapy
Figure 6. Speech Therapy
Figure 7. Others
Figure 8. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Application in 2022
Figure 10. Hospitals Picture
Figure 11. Specialty Centers Picture
Figure 12. Research Centers Picture
Figure 13. Others Picture
Figure 14. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Amyotrophic Lateral Sclerosis Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Region in 2022
Figure 19. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Amyotrophic Lateral Sclerosis Treatment Revenue Share by Players in 2022
Figure 25. Amyotrophic Lateral Sclerosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Amyotrophic Lateral Sclerosis Treatment Market Share in 2022
Figure 27. Global Top 6 Players Amyotrophic Lateral Sclerosis Treatment Market Share in 2022
Figure 28. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Share by Type (2018-2023)
Figure 29. Global Amyotrophic Lateral Sclerosis Treatment Market Share Forecast by Type (2024-2029)
Figure 30. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Share by Application (2018-2023)
Figure 31. Global Amyotrophic Lateral Sclerosis Treatment Market Share Forecast by Application (2024-2029)
Figure 32. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 42. France Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 49. China Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 52. India Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 66. Amyotrophic Lateral Sclerosis Treatment Market Drivers
Figure 67. Amyotrophic Lateral Sclerosis Treatment Market Restraints
Figure 68. Amyotrophic Lateral Sclerosis Treatment Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Amyotrophic Lateral Sclerosis Treatment in 2022
Figure 71. Manufacturing Process Analysis of Amyotrophic Lateral Sclerosis Treatment
Figure 72. Amyotrophic Lateral Sclerosis Treatment Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Amyotrophic Lateral Sclerosis Treatment Picture
Figure 2. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Type in 2022
Figure 4. Medication
Figure 5. Physical Therapy
Figure 6. Speech Therapy
Figure 7. Others
Figure 8. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Application in 2022
Figure 10. Hospitals Picture
Figure 11. Specialty Centers Picture
Figure 12. Research Centers Picture
Figure 13. Others Picture
Figure 14. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Amyotrophic Lateral Sclerosis Treatment Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Region in 2022
Figure 19. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Amyotrophic Lateral Sclerosis Treatment Revenue Share by Players in 2022
Figure 25. Amyotrophic Lateral Sclerosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Amyotrophic Lateral Sclerosis Treatment Market Share in 2022
Figure 27. Global Top 6 Players Amyotrophic Lateral Sclerosis Treatment Market Share in 2022
Figure 28. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Share by Type (2018-2023)
Figure 29. Global Amyotrophic Lateral Sclerosis Treatment Market Share Forecast by Type (2024-2029)
Figure 30. Global Amyotrophic Lateral Sclerosis Treatment Consumption Value Share by Application (2018-2023)
Figure 31. Global Amyotrophic Lateral Sclerosis Treatment Market Share Forecast by Application (2024-2029)
Figure 32. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 42. France Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Region (2018-2029)
Figure 49. China Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 52. India Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Amyotrophic Lateral Sclerosis Treatment Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Amyotrophic Lateral Sclerosis Treatment Consumption Value (2018-2029) & (USD Million)
Figure 66. Amyotrophic Lateral Sclerosis Treatment Market Drivers
Figure 67. Amyotrophic Lateral Sclerosis Treatment Market Restraints
Figure 68. Amyotrophic Lateral Sclerosis Treatment Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Amyotrophic Lateral Sclerosis Treatment in 2022
Figure 71. Manufacturing Process Analysis of Amyotrophic Lateral Sclerosis Treatment
Figure 72. Amyotrophic Lateral Sclerosis Treatment Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
